110 related articles for article (PubMed ID: 14614448)
1. DeltaNp73 can modulate the expression of various genes in a p53-independent fashion.
Kartasheva NN; Lenz-Bauer C; Hartmann O; Schäfer H; Eilers M; Dobbelstein M
Oncogene; 2003 Nov; 22(51):8246-54. PubMed ID: 14614448
[TBL] [Abstract][Full Text] [Related]
2. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
3. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
4. Questioning the oncogenic role of DeltaNp73alpha in different cell lines expressing p53 or not.
Marrazzo E; Marchini S; Previdi S; Broggini M
Cancer Biol Ther; 2006 Jul; 5(7):794-803. PubMed ID: 16721041
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs.
Sabatino MA; Previdi S; Broggini M
Int J Cancer; 2007 Feb; 120(3):506-13. PubMed ID: 17096333
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
7. DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.
Vella V; Puppin C; Damante G; Vigneri R; Sanfilippo M; Vigneri P; Tell G; Frasca F
Int J Cancer; 2009 Jun; 124(11):2539-48. PubMed ID: 19173293
[TBL] [Abstract][Full Text] [Related]
8. Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function.
Watanabe K; Ozaki T; Nakagawa T; Miyazaki K; Takahashi M; Hosoda M; Hayashi S; Todo S; Nakagawara A
J Biol Chem; 2002 Apr; 277(17):15113-23. PubMed ID: 11844794
[TBL] [Abstract][Full Text] [Related]
9. The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells.
Taverniti V; Krynska H; Venuti A; Straub ML; Sirand C; Lohmann E; Romero-Medina MC; Moro S; Robitaille A; Negroni L; Martinez-Zapien D; Masson M; Tommasino M; Zanier K
mSphere; 2023 Apr; 8(2):e0005623. PubMed ID: 36883841
[TBL] [Abstract][Full Text] [Related]
10. IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.
Accardi R; Scalise M; Gheit T; Hussain I; Yue J; Carreira C; Collino A; Indiveri C; Gissmann L; Sylla BS; Tommasino M
Mol Cell Biol; 2011 Jun; 31(11):2210-26. PubMed ID: 21482671
[TBL] [Abstract][Full Text] [Related]
11. DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.
Vilgelm A; Wei JX; Piazuelo MB; Washington MK; Prassolov V; El-Rifai W; Zaika A
Oncogene; 2008 Apr; 27(15):2170-6. PubMed ID: 17952118
[TBL] [Abstract][Full Text] [Related]
12. DeltaNp73beta is active in transactivation and growth suppression.
Liu G; Nozell S; Xiao H; Chen X
Mol Cell Biol; 2004 Jan; 24(2):487-501. PubMed ID: 14701724
[TBL] [Abstract][Full Text] [Related]
13. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
14. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
[TBL] [Abstract][Full Text] [Related]
15. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors.
Zaika E; Bhardwaj V; Wei J; Washington MK; Souza R; El-Rifai W; Zaika A
PLoS One; 2013; 8(5):e64306. PubMed ID: 23717592
[TBL] [Abstract][Full Text] [Related]
17. p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.
Miro-Mur F; Meiller A; Haddada H; May E
Oncogene; 2003 Aug; 22(35):5451-6. PubMed ID: 12934105
[TBL] [Abstract][Full Text] [Related]
18. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
[TBL] [Abstract][Full Text] [Related]
19. Melanocyte and keratinocyte carcinogenesis: p53 family protein activities and intersecting mRNA expression profiles.
Kulesz-Martin M; Lagowski J; Fei S; Pelz C; Sears R; Powell MB; Halaban R; Johnson J
J Investig Dermatol Symp Proc; 2005 Nov; 10(2):142-52. PubMed ID: 16363065
[TBL] [Abstract][Full Text] [Related]
20. p73 transcriptional activity increases upon cooperation between its spliced forms.
Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
